why is semaglutide being discontinued Adults with obesity who discontinue semaglutide, tirzepatide achieve minimal weight loss Doctors explain what really happens

doi: 10.1038/cr.2010.150 74 LoodCBlancoLPPurmalekMMCarmona-RiveraCDe RavinSSSmithCKet al

With a little planning, you can ensure your Ozempic pen remains effective wherever your journey takes you

Heart palpitations on semaglutide are usually indirect consequences of the body adjusting to a powerful metabolic medication, driven primarily by dehydration, electrolyte shifts, and the physiological demands of dose escalation

Tirzepatide spans 2.5mg to 15mg

Survodutide (BI 456906) is an investigational unimolecular dual agonist developed by Boehringer Ingelheim (licensed from Zealand Pharma) that activates both the glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR)